<code id='BD2F7A7D3B'></code><style id='BD2F7A7D3B'></style>
    • <acronym id='BD2F7A7D3B'></acronym>
      <center id='BD2F7A7D3B'><center id='BD2F7A7D3B'><tfoot id='BD2F7A7D3B'></tfoot></center><abbr id='BD2F7A7D3B'><dir id='BD2F7A7D3B'><tfoot id='BD2F7A7D3B'></tfoot><noframes id='BD2F7A7D3B'>

    • <optgroup id='BD2F7A7D3B'><strike id='BD2F7A7D3B'><sup id='BD2F7A7D3B'></sup></strike><code id='BD2F7A7D3B'></code></optgroup>
        1. <b id='BD2F7A7D3B'><label id='BD2F7A7D3B'><select id='BD2F7A7D3B'><dt id='BD2F7A7D3B'><span id='BD2F7A7D3B'></span></dt></select></label></b><u id='BD2F7A7D3B'></u>
          <i id='BD2F7A7D3B'><strike id='BD2F7A7D3B'><tt id='BD2F7A7D3B'><pre id='BD2F7A7D3B'></pre></tt></strike></i>

          Home / Wikipedia / explore

          explore


          explore

          author:comprehensive    Page View:4
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In